First Long Island Investors, LLC Amgen Inc Transaction History

First Long Island Investors, LLC

$1.25 Billion
Q3 2024

A detailed history of First Long Island Investors, LLC transactions in Amgen Inc stock. As of the latest transaction made, First Long Island Investors, LLC holds 82,741 shares of AMGN stock, worth $23.6 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares

82,741

Previous 83,141 0.48%

Holding current value

$23.6 Million

Previous $26 Million 2.63%

% of portfolio

2.13%

Previous 2.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $123,752 - $134,952	-400 Reduced 0.48%	82,741 $26.7 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $458,761 - $557,515	-1,746 Reduced 2.06%	83,141 $26 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $481,277 - $580,962	-1,790 Reduced 2.07%	84,887 $24.1 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $459,237 - $518,074	-1,796 Reduced 2.03%	86,677 $25 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $64,064 - $79,537	293 Added 0.33%	88,473 $23.8 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $141,203 - $166,970	659 Added 0.75%	88,180 $19.6 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $1.48 Million - $1.8 Million	-6,540 Reduced 6.95%	87,521 $21.2 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $147,266 - $187,119	-643 Reduced 0.68%	94,061 $24.7 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $177,547 - $200,241	-791 Reduced 0.83%	94,704 $21.3 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $935,990 - $1.04 Million	-4,057 Reduced 4.08%	95,495 $23.2 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $4.39 Million - $4.85 Million	20,009 Added 25.15%	99,552 $24.1 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $7.81 Million - $8.93 Million	-39,250 Reduced 33.04%	79,543 $17.9 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $748,039 - $876,418	3,524 Added 3.06%	118,793 $25.3 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $4.23 Million - $4.69 Million	-18,099 Reduced 13.57%	115,269 $28.1 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $143,575 - $167,314	-647 Reduced 0.48%	133,368 $33.2 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $4.98 Million - $5.94 Million	23,037 Added 20.76%	134,015 $30.8 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $85,412 - $94,985	364 Added 0.33%	110,978 $28.2 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $295,923 - $363,139	1,496 Added 1.37%	110,614 $26.1 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $580,798 - $770,297	3,187 Added 3.01%	109,118 $22.1 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $108,795 - $139,840	-575 Reduced 0.54%	105,931 $25.5 Million
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $123,966 - $148,537	-712 Reduced 0.66%	106,506 $20.6 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $1.7 Million - $2 Million	-10,219 Reduced 8.7%	107,218 $19.8 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $695,264 - $783,714	3,844 Added 3.38%	117,437 $22.3 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $1.77 Million - $2.07 Million	-9,928 Reduced 8.04%	113,593 $22.1 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $539,008 - $607,661	2,909 Added 2.41%	123,521 $25.6 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $1.84 Million - $2.06 Million	-11,063 Reduced 8.4%	120,612 $22.3 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $204,332 - $238,788	1,206 Added 0.92%	131,675 $22.4 Million
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $330,828 - $369,636	1,960 Added 1.53%	130,469 $22.7 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.86 Million - $2.12 Million	11,089 Added 9.44%	128,509 $24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	117,420	117,420 $0

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Long Island Investors, LLC with notifications on news.

Account

First Long Island Investors, LLC Amgen Inc Transaction History